Articles

Hypofractionated Radiation May Be New Treatment Paradigm in Patients Unable to Receive Standard of Care

By Phoebe Starr

ASTRO Annual Meeting

October 2016, Vol 7, No 9

FDA News - October 2016

FDA Approvals, News & Updates, In the News

October 2016, Vol 7, No 9

Radiation Boost Improves Local Control, Spares Salvage Mastectomy in Patients with Ductal Carcinoma in Situ

By Phoebe Starr

ASTRO Meeting Highlights

October 2016, Vol 7, No 9

Survival Increased with Value-Added Stereotactic Body Radiation Therapy in Patients with Lung Cancer

By Phoebe Starr

ASTRO Meeting Highlights

October 2016, Vol 7, No 9

Hematopoietic-Cell Transplants Require Substantial All-Cause Healthcare Resource Utilization

By Jessica Miller

Value in Oncology

October 2016, Vol 7, No 9

Palliative Care for Caregivers: Implementing Caregiver Support Programs

Palliative Care, Personalized Medicine

October 2016, Vol 7, No 9

Implementing Clinical Pathways May Not Lower Costs

By Jessica Miller

Clinical Pathways

October 2016, Vol 7, No 9

San Fransisco, CA—An economic model designed to determine the cost of instituting a clinical pathway inmetastatic colorectal cancer (mCRC) showed that the costs associated with implementing such a pathway may outweigh any potential cost-savings it may provide, at least for the near-term, according to Tanya G.K. Bentley, PhD, PHAR LLC, Beverly Hills, CA, and colleagues.

Role of Cancer Cell Count in Assessing Therapy Efficacy in Prostate Cancer

By Sophie Granger

Prostate Cancer, Solid Tumors

October 2016, Vol 7, No 9

Older Drugs in “New Clothes” Achieve Superior Outcomes

By Phoebe Starr

Hematologic Malignancies, Leukemia, Personalized Medicine

October 2016, Vol 7, No 9

In the Literature - October 2016

In the Literature

October 2016, Vol 7, No 9

Page 149 of 329